Marco Taricco - Founding Partner and Co-CIO - Bluebell Capital Partners Limited
EDITORIAL: Dual-class share structures lose favour among investors
Bluebell pressures Bayer to separate crop and pharma units
Elliott Reportedly Builds Stake in Drugmaker GSK
A £50 Billion Corporate Overhaul Linking Two Embattled Leaders - BNN Bloomberg
Glaxosmithkline boosted by HIV drug approval and US Covid treatments
Bayer Draws Attention from Activist Investors
Stock Spotlight: Haleon spinout boosts GSK but firm remains dependant on pipeline
New-look GSK faces moment of reckoning as consumer business spins off
Alan Jope Unilever: GSK rejects $68b Unilever bid for consumer healthcare unit, ET BrandEquity